Breaking News, Collaborations & Alliances

Charles River Extends Gene Therapy Alliance with NUS Medicine

Will support NUS Medicine in the development of engineered stem cells for cancer therapy.

Author Image

By: Charlie Sternberg

Associate Editor

Charles River Laboratories International, Inc. and National University of Singapore’s Yong Loo Lin School of Medicine (NUS Medicine), a medical education institution with a renowned medical research field of stem cell biology and therapy, have entered a High Quality (HQ) plasmid DNA development and manufacturing agreement.   NUS Medicine will utilize Charles River’s contract development and manufacturing organization (CDMO) expertise in HQ and GMP- compliant plasmid DNA, which serves as a crit...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters